IndieBio

General contacts
Investor type

VC

Founded

2014

AUM

-

Location

San Francisco, California, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Pre-seed Series A

Region of investment

North America
Investor profile last updated: 31 August, 2026

Profile

IndieBio is an accelerator and incubator program based in San Francisco, California, founded in 2014. It was Silicon Valley’s first biotech program to offer bio-labs on site as well as pre-seed investment to scientists ready to launch startups. The firm is part of SOSV and has expanded its focus to include deep tech sectors such as chemistry, physics, AI, and more. IndieBio's team consists of 20 professionals who support early-stage startups.

IndieBio invests in sectors like life sciences, high tech, biotechnology, climate, food and agriculture, and materials. The firm typically invests in seed-stage and early-stage companies, with an average check size of up to $525K. IndieBio primarily invests in the United States but has a presence in 21 countries. The firm has supported over 252 startups, including notable companies like RingCentral, Geltor, and Perfect Day.

Notable investments by IndieBio include Deep Root Biolabs - biotechnology, Fermeate - other commercial products, Augment Biologics - drug discovery, Supercool Earth - other commercial products, and Transition Metal Solutions - other metals, minerals, and mining. These investments highlight IndieBio's commitment to fostering innovation in diverse sectors.

Industry

ClimateTech HealthTech Life Sciences Food and Beverage Biotechnology Chemicals Industrial AI Technology Energy

Contacts

Name
Title
Email
Social Networks
avatar
Catherine Seo Investment Associate
Investment Associate
c•••@•••
LinkedIn
avatar
Bethany Watson (Schwartz) Program Manager
Program Manager
b•••@•••
LinkedIn
Upgrade to see contacts
avatar
OEtmCSkNfXLFiz7v OEtmCSkNfXLFiz7v
OEtmCSkNfXLFiz7v
[email protected]
linkedin twitter
avatar
OEtmCSkNfXLFiz7v OEtmCSkNfXLFiz7v
OEtmCSkNfXLFiz7v
[email protected]
linkedin twitter
avatar
OEtmCSkNfXLFiz7v OEtmCSkNfXLFiz7v
OEtmCSkNfXLFiz7v
[email protected]
linkedin twitter
Investment-team contacts for IndieBio — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about IndieBio

IndieBio is a venture capital firm. It backs companies at Seed, Pre-seed and Series A, writing tickets of $0-1 m.
IndieBio is located in San Francisco, California, United States.
IndieBio was founded in 2014.
IndieBio invests in companies and startups in ClimateTech, HealthTech, Life Sciences, Food and Beverage, Biotechnology, Chemicals, Industrial, AI, Technology, Energy.
IndieBio invests in companies and startups in North America.
IndieBio invests in companies and startups at Seed, Pre-seed, Series A.
IndieBio usually invests $0-1 m on average.
IndieBio can be reached through its website indiebio.co, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for IndieBio — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query IndieBio directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.